Brand-name Wegovy, Zepbound, and Ozempic versus provider-prescribed compounded semaglutide and tirzepatide — the differences in cost, access, and FDA status, so you can talk to a licensed provider with clear information.
How brand-name Wegovy compares with provider-prescribed compounded semaglutide — and the other GLP-1 options worth knowing.
Read the comparison →How brand-name Zepbound compares with provider-prescribed compounded tirzepatide, plus the semaglutide option.
Read the comparison →Ozempic is approved for diabetes, not weight loss — here are the options people actually use for weight management.
Read the comparison →The two leading GLP-1 molecules, compared on mechanism, cost, and what a provider weighs when choosing.
Read the comparison →A plain-English explainer on 503A compounding, FDA status, cost, and how to choose a legitimate provider.
Read the comparison →